Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community

被引:4
|
作者
Diaz, Javier [1 ]
Martinez, Fernando [1 ,2 ]
Miguel Calderon, Jose [1 ]
Fernandez, Antonio [1 ]
Sauri, Inmaculada [1 ]
Uso, Ruth [1 ]
Luis Trillo, Jose [1 ]
Redon, Josep [1 ,3 ]
Jose Forner, Maria [1 ,2 ]
机构
[1] Univ Valencia, INCLIVA Res Inst, Cardiovasc & Renal Res Grp, Valencia, Spain
[2] Internal Med Hosp Clin Valencia, Valencia, Spain
[3] CIBERObn Carlos III Inst, Madrid, Spain
来源
ESC HEART FAILURE | 2022年 / 9卷 / 06期
关键词
Heart failure; Atrial fibrillation; Hospitalization; Renal function; Stroke; All-cause mortality; CHRONIC KIDNEY-DISEASE; RISK; ASSOCIATIONS; PREDICTORS;
D O I
10.1002/ehf2.14124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The objective of the present study is to assess the bidirectional association between heart failure (HF) and atrial fibrillation (AF) using real-world data. Methods and results From an electronic health recording with a population of 3 799 885 adult subjects, those with prevalent or incident HF were selected and followed throughout a study period of 5 years. Prevalence and incidence of AF, and their impact in the risk for acute HF hospitalization, worsening renal function, ischaemic and haemorrhagic stroke, and all-cause mortality were identified. We analysed all incident and prevalent patients with HF and AF, 128 086 patients (S1), and subsequently analysed a subset of patients with incident HF and AF, 57 354 patients (S2). We analysed all incident and prevalent patients with HF and AF, 128 086 patients (S1), and subsequently a subset of patients with incident HF and AF, 57 354 patients (S2). The prevalence of AF was 59 906 (46.7%) of the HF patients, while incidence in the 52 was 231/1000 patients/year. In both cohorts, S1 and S2, AF significantly increases the risk of acute heart failure hospitalization [incidence 79.1/1000 and 97.5/1000 patients/year; HR 1.53 (1.48-1.59 95% CI) and HR 1.32 (1.24-1.41 95% CI), respectively], risk of decreased renal function (eGFR reduced by >20%) [66.2/1000 and 94.0/1000 patients/year; HR 1.13 (1.09-1.18 95% CI) and HR 1.22 (1.14-1.31 95% CI), respectively] and all-cause mortality [203/1000 and 294/1000 patients/year; HR 1.62 (1.58-1.65 95% CI) and HR 1.65 (1.59-1.70 95% CI), respectively]. The number of episodes of hospitalization for acute heart failure was also significantly higher in the AF patients (27 623 vs. 10 036, P < 0.001). However, the risk for ischaemic stroke was reduced in the AF subjects [HR 0.66 (0.63-0.74 95% Cl)), probably due to the anticoagulant treatment. Conclusions AF is associated with an increment in the risk of episodes of acute heart failure as well as decline of renal function and increment of all-cause mortality.
引用
收藏
页码:4230 / 4239
页数:10
相关论文
共 50 条
  • [31] Safety and efficacy of apixaban, dabigatran and rivaroxaban in obese and morbidly obese patients with heart failure and atrial fibrillation: A real-world analysis
    Chugh, Yashasvi
    Gupta, Kashvi
    Krishna, Hanumanthu Balram
    Ayala, Renato Quispe
    Zepeda, Ignacio
    Grushko, Michael
    Faillace, Robert T.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2023, 46 (01): : 50 - 58
  • [32] Catheter ablation is associated with reduced all-cause mortality in a real-world cohort of patients with atrial fibrillation and heart failure
    Samuel, M.
    Abrahamowicz, M.
    Joza, J.
    Essebag, V.
    Pilote, L.
    EUROPEAN HEART JOURNAL, 2019, 40 : 617 - 617
  • [33] Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
    Amy Groenewegen
    Victor W. Zwartkruis
    Betül Cekic
    Rudolf. A. de Boer
    Michiel Rienstra
    Arno W. Hoes
    Frans H. Rutten
    Monika Hollander
    Cardiovascular Diabetology, 20
  • [34] Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
    Groenewegen, Amy
    Zwartkruis, Victor W.
    Cekic, Betul
    de Boer, Rudolf. A.
    Rienstra, Michiel
    Hoes, Arno W.
    Rutten, Frans H.
    Hollander, Monika
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [35] Diabetes and treatment of chronic heart failure in a large real-world heart failure population
    Radhoe, Sumant P.
    Veenis, Jesse F.
    Linssen, Gerard C. M.
    van der Lee, Chris
    Eurlings, Luc W. M.
    Kragten, Hans
    Al-Windy, Nadea Y. Y.
    van der Spank, Aukje
    Koudstaal, Stefan
    Brunner-La Rocca, Hans-Peter
    Brugts, Jasper J.
    ESC HEART FAILURE, 2022, 9 (01): : 353 - 362
  • [36] Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data
    Listratov, A. I.
    Ivanov, I. I.
    Ziskina, N. K.
    Efimenko, V. V.
    Zhavoronkova, A. V.
    Miliakova, E. S.
    Kudrjavtseva, A. A.
    Napalkov, D. A.
    Sokolova, A. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2024, 20 (04)
  • [37] Real-World Heart Failure Burden in Thai Patients
    Jiampo, Panyapat
    Tangkittikasem, Thidaporn
    Boonyapiphat, Thanita
    Senthong, Vichai
    Torpongpun, Artit
    CARDIOLOGY AND THERAPY, 2024, 13 (02) : 281 - 297
  • [38] Real-World Heart Failure Burden in Thai Patients
    Panyapat Jiampo
    Thidaporn Tangkittikasem
    Thanita Boonyapiphat
    Vichai Senthong
    Artit Torpongpun
    Cardiology and Therapy, 2024, 13 : 281 - 297
  • [39] The impact of chronic heart failure on heart remodeling in patients with atrial fibrillation
    Syvolap, V. V.
    Lysenko, V. A.
    ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (04) : 462 - 468
  • [40] Impact of Age on Atrial Fibrillation Detection among a Large, Real-World Population of Cryptogenic Stroke Patients with Insertable Cardiac Monitors
    Richards, Mark
    Rogers, John D.
    Ferreira, Scott W.
    Nichols, Allan J.
    Koehler, Jodi L.
    Sarkar, Shantanu
    Ziegler, Paul D.
    STROKE, 2016, 47